Jenburkt Pharmaceuticals submits daily report

12 Jan 2023 Evaluate

Pursuant to provisions of Regulation 18(i) of the Buy-back Regulations, Jenburkt Pharmaceuticals has submitted the daily report with respect to Equity Shares bought back by the Company on 12th January, 2023. The details will also be made available on the website of the Company: www.jenburkt.com.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1071.30 31.30 (3.01%)
03-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...